{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:18:05Z","timestamp":1782436685617,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1208\/s12249-017-0782-5","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T13:12:46Z","timestamp":1493989966000},"page":"2977-2986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Inducing Controlled Release and Increased Tumor-Targeted Delivery of Chlorambucil via Albumin\/Liposome Hybrid Nanoparticles"],"prefix":"10.1208","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7693-7823","authenticated-orcid":false,"given":"Quan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingliang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiurong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"issue":"3\u20134","key":"782_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.drudis.2011.09.015","volume":"17","author":"M Slingerland","year":"2012","unstructured":"Slingerland M, Guchelaar HJ, Gelderblom H. Liposomal drug formulations in cancer therapy: 15 years along the road. Drug Discov Today. 2012;17(3\u20134):160\u20136. doi:\n10.1016\/j.drudis.2011.09.015\n\n.","journal-title":"Drug Discov Today"},{"issue":"20","key":"782_CR2","doi-asserted-by":"publisher","first-page":"9298","DOI":"10.1039\/c4nr04730c","volume":"7","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhang X, Chen T, Wang X, Fu Y, Jin Y, et al. A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1\/21-47 domain of hepatitis B virus. Nanoscale. 2015;7(20):9298\u2013310. doi:\n10.1039\/c4nr04730c\n\n.","journal-title":"Nanoscale"},{"issue":"1\u20132","key":"782_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijpharm.2007.12.030","volume":"356","author":"G Xiang","year":"2008","unstructured":"Xiang G, Wu J, Lu Y, Liu Z, Lee RJ. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm. 2008;356(1\u20132):29\u201336. doi:\n10.1016\/j.ijpharm.2007.12.030\n\n.","journal-title":"Int J Pharm"},{"issue":"11","key":"782_CR4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/bjc.1996.625","volume":"74","author":"D Goren","year":"1996","unstructured":"Goren D, Horowitz AT, Zalipsky S, Woodle MC, Yarden Y, Gabizon A. Targeting of stealth liposomes to erbB-2 (Her\/2) receptor: in vitro and in vivo studies. Br J Cancer. 1996;74(11):1749\u201356.","journal-title":"Br J Cancer"},{"issue":"3\u20134","key":"782_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejps.2005.05.012","volume":"26","author":"A Fahr","year":"2005","unstructured":"Fahr A, Hoogevest P, May S, Bergstrand N. S. Leigh ML. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. Eur J Pharm Sci. 2005;26(3\u20134):251\u201365. doi:\n10.1016\/j.ejps.2005.05.012\n\n.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"782_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2005.01.010","volume":"104","author":"IV Zhigaltsev","year":"2005","unstructured":"Zhigaltsev IV, Maurer N, Akhong QF, Leone R, Leng E, Wang J, et al. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. J Control Release. 2005;104(1):103\u201311. doi:\n10.1016\/j.jconrel.2005.01.010\n\n.","journal-title":"J Control Release"},{"issue":"1A","key":"782_CR7","first-page":"331","volume":"25","author":"A Pal","year":"2005","unstructured":"Pal A, Khan S, Wang Y-F, Kamath N, Sarkar AK, Ahmad A, et al. Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation. Anticancer Res. 2005;25(1A):331\u201341.","journal-title":"Anticancer Res"},{"issue":"11","key":"782_CR8","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1002\/jps.21358","volume":"97","author":"DC Drummond","year":"2008","unstructured":"Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J Pharm Sci. 2008;97(11):4696\u2013740. doi:\n10.1002\/jps.21358\n\n.","journal-title":"J Pharm Sci"},{"issue":"1\u20133","key":"782_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0009-3084(93)90067-D","volume":"64","author":"S Amselem","year":"1993","unstructured":"Amselem S, Cohen R, Barenholz Y. In vitro tests to predict in vivo performance of liposomal dosage forms. Chem Phys Lipids. 1993;64(1\u20133):219\u201337. doi:\n10.1016\/0009-3084(93)90067-D\n\n.","journal-title":"Chem Phys Lipids"},{"issue":"2","key":"782_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","volume":"157","author":"AO Elzoghby","year":"2012","unstructured":"Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157(2):168\u201382. doi:\n10.1016\/j.jconrel.2011.07.031\n\n.","journal-title":"J Control Release"},{"issue":"7","key":"782_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1163\/156856295x00526","volume":"7","author":"RK Panduranga","year":"1996","unstructured":"Panduranga RK. Recent developments of collagen-based materials for medical applications and drug delivery systems. J Biomater Sci Polym Ed. 1996;7(7):623\u201345. doi:\n10.1163\/156856295x00526\n\n.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"3","key":"782_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","volume":"132","author":"F Kratz","year":"2008","unstructured":"Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release. 2008;132(3):171\u201383. doi:\n10.1016\/j.jconrel.2008.05.010\n\n.","journal-title":"J Control Release"},{"issue":"11","key":"782_CR13","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1021\/acs.molpharmaceut.5b00536","volume":"12","author":"X Yi","year":"2015","unstructured":"Yi X, Lian X, Dong J, Wan Z, Xia C, Song X, et al. Co-delivery of pirarubicin and paclitaxel by human serum albumin nanoparticles to enhance antitumor effect and reduce systemic toxicity in breast cancers. Mol Pharm. 2015;12(11):4085\u201398. doi:\n10.1021\/acs.molpharmaceut.5b00536\n\n.","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"782_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijpharm.2015.04.047","volume":"487","author":"X He","year":"2015","unstructured":"He X, Xiang N, Zhang J, Zhou J, Fu Y, Gong T, et al. Encapsulation of teniposide into albumin nanoparticles with greatly lowered toxicity and enhanced antitumor activity. Int J Pharm. 2015;487(1\u20132):250\u20139. doi:\n10.1016\/j.ijpharm.2015.04.047\n\n.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"782_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ijpharm.2015.08.011","volume":"493","author":"MI Tadros","year":"2015","unstructured":"Tadros MI, Al-mahallawi AM. Long-circulating lipoprotein-mimic nanoparticles for smart intravenous delivery of a practically-insoluble antineoplastic drug: development, preliminary safety evaluations and preclinical pharmacokinetic studies. Int J Pharm. 2015;493(1\u20132):439\u201350. doi:\n10.1016\/j.ijpharm.2015.08.011\n\n.","journal-title":"Int J Pharm"},{"key":"782_CR16","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.6b13738","author":"C Deng","year":"2016","unstructured":"Deng C, Zhang Q, Fu Y, Sun X, Gong T, Zhang Z. Coadministration of oligomeric hyaluronic acid-modified liposomes with tumor-penetrating peptide-iRGD enhances the antitumor efficacy of doxorubicin against melanoma. ACS Appl Mater Interfaces. 2016; doi:\n10.1021\/acsami.6b13738\n\n.","journal-title":"ACS Appl Mater Interfaces"},{"key":"782_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpba.2014.07.010","volume":"99","author":"XY Wang","year":"2014","unstructured":"Wang XY, Zhang Q, Lin Q, Zhang Y, Zhang ZR. Validated LC-MS\/MS method for the simultaneous determination of chlorambucil and its prodrug in mouse plasma and brain, and application to pharmacokinetics. J Pharm Biomed Anal. 2014;99:74\u20138. doi:\n10.1016\/j.jpba.2014.07.010\n\n.","journal-title":"J Pharm Biomed Anal"},{"key":"782_CR18","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.2147\/ijn.s105427","volume":"11","author":"P Sun","year":"2016","unstructured":"Sun P, Huang W, Jin M, Wang Q, Fan B, Kang L, et al. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis. Int J Nanomedicine. 2016;11:4931\u201345. doi:\n10.2147\/ijn.s105427\n\n.","journal-title":"Int J Nanomedicine"},{"issue":"1\u20132","key":"782_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijpharm.2010.06.028","volume":"396","author":"K Tanaka","year":"2010","unstructured":"Tanaka K, Kanazawa T, Shibata Y, Suda Y, Fukuda T, Takashima Y, et al. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery. Int J Pharm. 2010;396(1\u20132):229\u201338. doi:\n10.1016\/j.ijpharm.2010.06.028\n\n.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"782_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijpharm.2016.01.033","volume":"500","author":"S Guan","year":"2016","unstructured":"Guan S, Li L, Zhu X, Yang Y, Zhang Z, Huang Y. An in vitro investigation of a detachable fork-like structure as efficient nuclear-targeted sub-unit in A2780 cell cultures. Int J Pharm. 2016;500(1\u20132):100\u20139. doi:\n10.1016\/j.ijpharm.2016.01.033\n\n.","journal-title":"Int J Pharm"},{"issue":"13","key":"782_CR21","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2217\/fon.15.91","volume":"11","author":"S Friberg","year":"2015","unstructured":"Friberg S, Nystr\u00f6m AM. Nanotechnology in the war against cancer: new arms against an old enemy-a clinical view. Future Oncol. 2015;11(13):1961\u201375. doi:\n10.2217\/fon.15.91\n\n.","journal-title":"Future Oncol"},{"issue":"9916","key":"782_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S0140-6736(13)62226-6","volume":"383","author":"D Hanahan","year":"2014","unstructured":"Hanahan D. Rethinking the war on cancer. Lancet. 2014;383(9916):558\u201363. doi:\n10.1016\/S0140-6736(13)62226-6\n\n.","journal-title":"Lancet"},{"issue":"1","key":"782_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijpharm.2013.07.079","volume":"457","author":"C Feng","year":"2013","unstructured":"Feng C, Wang Z, Jiang C, Kong M, Zhou X, Li Y, et al. Chitosan\/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. Int J Pharm. 2013;457(1):158\u201367. doi:\n10.1016\/j.ijpharm.2013.07.079\n\n.","journal-title":"Int J Pharm"},{"issue":"10","key":"782_CR24","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1021\/mp400303w","volume":"10","author":"J Zhou","year":"2013","unstructured":"Zhou J, Zhang X, Li M, Wu W, Sun X, Zhang L, et al. Novel lipid hybrid albumin nanoparticle greatly lowered toxicity of pirarubicin. Mol Pharm. 2013;10(10):3832\u201341. doi:\n10.1021\/mp400303w\n\n.","journal-title":"Mol Pharm"},{"issue":"12","key":"782_CR25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1039\/C5BM00161G","volume":"3","author":"J Cao","year":"2015","unstructured":"Cao J, Wang R, Gao N, Li M, Tian X, Yang W, et al. A7RC peptide modified paclitaxel liposomes dually target breast cancer. Biomater Sci. 2015;3(12):1545\u201354. doi:\n10.1039\/C5BM00161G\n\n.","journal-title":"Biomater Sci"},{"issue":"6","key":"782_CR26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1208\/s12248-016-9961-7","volume":"18","author":"H Havel","year":"2016","unstructured":"Havel H, Finch G, Strode P, Wolfgang M, Zale S, Bobe I, et al. Nanomedicines: from bench to bedside and beyond. AAPS J. 2016;18(6):1373\u20138.","journal-title":"AAPS J"},{"issue":"3","key":"782_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.addr.2010.09.003","volume":"63","author":"K Maruyama","year":"2011","unstructured":"Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev. 2011;63(3):161\u20139. doi:\n10.1016\/j.addr.2010.09.003\n\n.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"782_CR28","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1039\/C3TB21423K","volume":"2","author":"M Li","year":"2014","unstructured":"Li M, Yu H, Wang T, Chang N, Zhang J, Du D, et al. Tamoxifen embedded in lipid bilayer improves the oncotarget of liposomal daunorubicin in vivo. J Mater Chem B. 2014;2(12):1619\u201325. doi:\n10.1039\/C3TB21423K\n\n.","journal-title":"J Mater Chem B"},{"issue":"1","key":"782_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0014-2964(79)90207-X","volume":"15","author":"HF Dullens","year":"1979","unstructured":"Dullens HF, De Weger RA, Vennegoor C, Den Otter W. Anti-tumour effect of chlorambucil-antibody complexes in a murine melanoma system. Eur J Cancer (1965). 1979;15(1):69\u201375. doi:\n10.1016\/0014-2964(79)90207-X\n\n.","journal-title":"Eur J Cancer (1965)"},{"issue":"1","key":"782_CR30","first-page":"1","volume":"21","author":"NH Greig","year":"1987","unstructured":"Greig NH, Sweeney DJ, Rapoport SI. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat. Cancer Chemother Pharmacol. 1987;21(1):1\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"782_CR31","volume-title":"Clarke\u2019s analysis of drugs and poisons: in pharmaceuticals, body fluids and postmortem material","author":"EGC Clarke","year":"2004","unstructured":"Clarke EGC, Moffat AC, Osselton MD, Widdop B. Clarke\u2019s analysis of drugs and poisons: in pharmaceuticals, body fluids and postmortem material. London: Pharmaceutical Press; 2004."},{"issue":"5","key":"782_CR32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00558252","volume":"35","author":"P Hartvig","year":"1988","unstructured":"Hartvig P, Simonsson B, \u00d6berg G, Wallin I, Ehrsson H. Inter- and intraindividual differences in oral chlorambucil pharmacokinetics. Eur J Clin Pharmacol. 1988;35(5):551\u20134.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"782_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejps.2013.06.012","volume":"50","author":"M Elmowafy","year":"2013","unstructured":"Elmowafy M, Viitala T, Ibrahim HM, Abu-Elyazid SK, Samy A, Kassem A, et al. Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake. Eur J Pharm Sci. 2013;50(2):161\u201371. doi:\n10.1016\/j.ejps.2013.06.012\n\n.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"782_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505\u201315. doi:\n10.1021\/mp800051m\n\n.","journal-title":"Mol Pharm"},{"key":"782_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.apsusc.2016.07.082","volume":"389","author":"S Reymond-Laruinaz","year":"2016","unstructured":"Reymond-Laruinaz S, Saviot L, Potin V, de Lucas MDCM. Protein-nanoparticle interaction in bioconjugated silver nanoparticles: a transmission electron microscopy and surface enhanced Raman spectroscopy study. Appl Surf Sci. 2016;389:17\u201324. doi:\n10.1016\/j.apsusc.2016.07.082\n\n.","journal-title":"Appl Surf Sci"},{"issue":"7\u20138","key":"782_CR36","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1007\/s00216-010-4104-y","volume":"398","author":"AL Capriotti","year":"2010","unstructured":"Capriotti AL, Caracciolo G, Caruso G, Cavaliere C, Pozzi D, Samperi R, et al. Analysis of plasma protein adsorption onto DC-Chol-DOPE cationic liposomes by HPLC-CHIP coupled to a Q-TOF mass spectrometer. Anal Bioanal Chem. 2010;398(7\u20138):2895\u2013903. doi:\n10.1007\/s00216-010-4104-y\n\n.","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"782_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(97)00128-2","volume":"32","author":"SC Semple","year":"1998","unstructured":"Semple SC, Chonn A, Cullis PR. Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo. Adv Drug Deliv Rev. 1998;32(1):3\u201317. doi:\n10.1016\/S0169-409X(97)00128-2\n\n.","journal-title":"Adv Drug Deliv Rev"},{"issue":"33","key":"782_CR38","doi-asserted-by":"publisher","first-page":"8521","DOI":"10.1016\/j.biomaterials.2013.07.102","volume":"34","author":"Q Peng","year":"2013","unstructured":"Peng Q, Zhang S, Yang Q, Zhang T, Wei X-Q, Jiang L, et al. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials. 2013;34(33):8521\u201330. doi:\n10.1016\/j.biomaterials.2013.07.102\n\n.","journal-title":"Biomaterials"},{"issue":"1","key":"782_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijpharm.2012.04.054","volume":"431","author":"LN Ramana","year":"2012","unstructured":"Ramana LN, Sharma S, Sethuraman S, Ranga U, Krishnan UM. Investigation on the stability of saquinavir loaded liposomes: implication on stealth, release characteristics and cytotoxicity. Int J Pharm. 2012;431(1):120\u20139. doi:\n10.1016\/j.ijpharm.2012.04.054\n\n.","journal-title":"Int J Pharm"},{"issue":"4","key":"782_CR40","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1021\/mp900090z","volume":"6","author":"E Gullotti","year":"2009","unstructured":"Gullotti E, Yeo Y. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol Pharm. 2009;6(4):1041\u201351. doi:\n10.1021\/mp900090z\n\n.","journal-title":"Mol Pharm"},{"issue":"6","key":"782_CR41","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/aps.2014.26","volume":"35","author":"L Zhang","year":"2014","unstructured":"Zhang L, Zhang S, Ruan S, Zhang Q, He Q, Gao H. Lapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism. Acta Pharmacol Sin. 2014;35(6):846\u201352. doi:\n10.1038\/aps.2014.26\n\n.","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"782_CR42","first-page":"737","volume":"65","author":"X Sun","year":"2010","unstructured":"Sun X, Li F, Wang Y, Liang W. Cellular uptake and elimination of lipophilic drug delivered by nanocarriers. Pharmazie. 2010;65(10):737\u201342.","journal-title":"Pharmazie"},{"issue":"1","key":"782_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1021\/acs.molpharmaceut.6b00932","volume":"14","author":"C Deng","year":"2017","unstructured":"Deng C, Jia M, Wei G, Tan T, Fu Y, Gao H, et al. Inducing optimal antitumor immune response through coadministering iRGD with pirarubicin loaded nanostructured lipid carriers for breast cancer therapy. Mol Pharm. 2017;14(1):296\u2013309. doi:\n10.1021\/acs.molpharmaceut.6b00932\n\n.","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"782_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2008.09.032","volume":"367","author":"P Sharma","year":"2009","unstructured":"Sharma P, Ganta S, Denny WA, Garg S. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: chlorambucil. Int J Pharm. 2009;367(1\u20132):187\u201394. doi:\n10.1016\/j.ijpharm.2008.09.032\n\n.","journal-title":"Int J Pharm"},{"issue":"1","key":"782_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1208\/s12248-016-9958-2","volume":"19","author":"W Yuan","year":"2017","unstructured":"Yuan W, Kuai R, Dai Z, Yuan Y, Zheng N, Jiang W, et al. Development of a flow-through USP-4 apparatus drug release assay to evaluate doxorubicin liposomes. AAPS J. 2017;19(1):150\u201360. doi:\n10.1208\/s12248-016-9958-2\n\n.","journal-title":"AAPS J"},{"issue":"4","key":"782_CR46","first-page":"987","volume":"54","author":"A Gabizon","year":"1994","unstructured":"Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 1994;54(4):987\u201392.","journal-title":"Cancer Res"},{"key":"782_CR47","first-page":"669","volume":"5","author":"D Zhao","year":"2010","unstructured":"Zhao D, Zhao X, Yuangang Z, Li J, Yu Z, Jiang R, et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine. 2010;5:669\u201377.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"782_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","volume":"1151","author":"G Haran","year":"1993","unstructured":"Haran G, Cohen R, Bar LK, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta Biomembr. 1993;1151(2):201\u201315. doi:\n10.1016\/0005-2736(93)90105-9\n\n.","journal-title":"Biochim Biophys Acta Biomembr"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-017-0782-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T11:24:35Z","timestamp":1508844275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-017-0782-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1208\/s12249-017-0782-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]}}}